30 January 2025 Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF read more
13 January 2025 Lilly to Acquire Scorpion Therapeutics’ Mutant-Selective PI3Kα Inhibitor Program read more
8 January 2025 LB Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial of LB-102 in Schizophrenia read more
12 December 2024 Vida Ventures Acknowledges the Passing of One of Our Friends and Founders, David Bonderman read more
1 October 2024 Halda Therapeutics Appoints Veteran Biopharma Leader, Christian Schade, as President and Chief Executive Officer read more
